Drug:
Reaction: URINARY TRACT INFECTION
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26899394 |
US |
||
Diabetic ketoacidosis, Urinary tract infection, |
||||
EMPAGLIFLOZIN, |
||||
| 302 | 26899525 |
US |
77 | 2 |
Bladder catheterisation, Malaise, Bone disorder, Device related infection, Urinary tract infection, Urinary retention, |
||||
VIBEGRON, |
||||
| 303 | 26899564 |
CO |
32 | |
Nausea, Vomiting, Hypotension, Agitation, Urinary tract infection, Blood creatinine decreased, Hypoxia, |
||||
FUROSEMIDE, SACUBITRIL AND VALSARTAN, |
||||
| 304 | 26899586 |
US |
40 | 2 |
Proteinuria, Urinary tract infection, Glomerular filtration rate decreased, Hypertension, |
||||
VOCLOSPORIN, |
||||
| 305 | 26899693 |
US |
2 | |
Urinary tract infection, Dehydration, |
||||
TIRZEPATIDE, |
||||
| 306 | 26899713 |
US |
88 | 1 |
Urinary tract infection, Pruritus, Rash, Prostatic operation, |
||||
DUPILUMAB, BUSPIRONE HYDROCHLORIDE, CLONAZEPAM, FAMOTIDINE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GLIPIZIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ICOSAPENT ETHYL, ICOSAPENT ETHYL CAPSULES, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, METHENAMINE HIPPURATE, PIOGLITAZONE, ROSUVASTATIN CALCIUM, LINAGLIPTIN, ACETAMINOPHEN, VALSARTAN, VALSARTAN ORAL, VITAMIN C, ERGOCALCIFEROL, BUSPIRONE HYDROCHLORIDE, |
||||
| 307 | 26899848 |
US |
2 | |
Urinary tract infection, Feeding disorder, Nausea, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 308 | 26899942 |
US |
83 | |
Urinary tract infection, Dyspepsia, Haemorrhoids, Diarrhoea, Blood urine present, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, STANDARDIZED SENNA CONCENTRATE, |
||||
| 309 | 26900201 |
JP |
87 | 1 |
Pneumonia, Influenza, Infection, Respiratory tract infection, Urinary tract infection, |
||||
RAVULIZUMAB, ECULIZUMAB, DANICOPAN, |
||||
| 310 | 26900610 |
US |
2 | |
Urinary tract infection, |
||||
UPADACITINIB, |
||||
| 311 | 26900676 |
JP |
84 | 2 |
Prerenal failure, Urinary tract infection, Cystitis, Renal disorder, Blood urea decreased, Cystatin C increased, Faeces soft, Blood creatinine increased, Diarrhoea, |
||||
TEPOTINIB HYDROCHLORIDE, |
||||
| 312 | 26900679 |
70 | ||
Myocardial infarction, Urinary tract infection, Muscular weakness, Muscle twitching, |
||||
PALTUSOTINE, PALTUSOTINE, ROSUVASTATIN, |
||||
| 313 | 26900866 |
US |
77 | 2 |
Spinal operation, Pyrexia, Rash, Urinary tract infection, Depression, Drug ineffective, Herpes zoster, Psychiatric symptom, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, DEUTETRABENAZINE, TRAZODONE HYDROCHLORIDE, CELECOXIB, CYCLOBENZAPRINE, GABAPENTIN, PRAZOSIN HYDROCHLORIDE, SIMVASTATIN, SPIRONOLACTONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 314 | 26900942 |
JP |
58 | 2 |
Influenza, Infection, Urinary tract infection, |
||||
RAVULIZUMAB, ECULIZUMAB, DANICOPAN, |
||||
| 315 | 26900944 |
JP |
67 | 1 |
Urinary tract infection, Pneumonia, Myasthenia gravis, COVID-19, Oropharyngeal pain, Pyrexia, |
||||
RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, TACROLIMUS, TACROLIMUS, CYCLOSPORINE, AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL, LANSOPRAZOLE, SIMVASTATIN, |
||||
| 316 | 26901477 |
US |
63 | 2 |
Urinary tract infection, Multiple sclerosis, Muscle tightness, |
||||
CLADRIBINE, |
||||
| 317 | 26901812 |
US |
2 | |
Urinary tract infection, Blood sodium decreased, Blood potassium decreased, |
||||
ACALABRUTINIB, |
||||
| 318 | 26901832 |
US |
2 | |
Neoplasm, Urinary tract infection, |
||||
CAPIVASERTIB, |
||||
| 319 | 26902129 |
US |
2 | |
Eye disorder, Urinary tract infection, Myalgia, Back pain, Arthralgia, Vision blurred, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, FISH OIL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LISINOPRIL, CYCLOSPORINE, SERTRALINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, |
||||
| 320 | 26902188 |
EU |
36 | 2 |
Urinary tract infection, Erysipelas, |
||||
FREMANEZUMAB-VFRM, |
||||
| 321 | 26902441 |
US |
44 | 2 |
Urinary tract infection, |
||||
RILZABRUTINIB, |
||||
| 322 | 26902598 |
US |
56 | 2 |
Pancreatitis, Urinary tract infection, Dehydration, Blood magnesium decreased, Hypotension, |
||||
PANCRELIPASE, |
||||
| 323 | 26892472 |
IN |
9 | 1 |
Pneumonia, Urinary tract infection, |
||||
RITUXIMAB, |
||||
| 324 | 26892498 |
CA |
74 | |
Urinary tract infection, Dyspnoea, Blood glucose increased, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 325 | 26892577 |
US |
2 | |
Feeling abnormal, Cold sweat, Migraine, Ear pain, Insomnia, Urinary tract infection, Chills, |
||||
DUPILUMAB, |
||||
| 326 | 26892676 |
US |
2 | |
Cardiac disorder, Visual impairment, Urinary tract infection, Hypertension, |
||||
EVOLOCUMAB, |
||||
| 327 | 26892717 |
US |
55 | 2 |
Urinary tract infection, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
| 328 | 26892940 |
US |
72 | 2 |
Urinary tract infection, |
||||
LENALIDOMIDE, ALLOPURINOL, CARVEDILOL, CLONIDINE, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, NIFEDIPINE, |
||||
| 329 | 26892956 |
EU |
80 | 1 |
Suspiciousness, Urinary tract infection, Incoherent, Confusional state, Delusion, |
||||
FOSCARBIDOPA/FOSLEVODOPA, SAFINAMIDE MESYLATE, RIVASTIGMINE, RIVASTIGMINE, QUETIAPINE, QUETIAPINE, |
||||
| 330 | 26893178 |
EU |
34 | 2 |
Pulmonary embolism, Arm amputation, Embolism arterial, Peripheral ischaemia, Soft tissue necrosis, Infarction, Paradoxical embolism, Arterial occlusive disease, Genital herpes, Cardiac ventricular thrombosis, Thrombocytosis, Microcytic anaemia, Urinary tract infection, Chest pain, Product use in unapproved indication, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, SUMATRIPTAN SUCCINATE, OXAZEPAM, INDOMETHACIN, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 331 | 26893610 |
JP |
||
Urinary tract infection, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 332 | 26893623 |
US |
89 | 2 |
Urinary tract infection, Stomatitis, Asthenia, Feeding disorder, |
||||
ELTROMBOPAG, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, |
||||
| 333 | 26893856 |
US |
1 | |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 334 | 26893965 |
GB |
67 | |
Prostatic operation, Knee operation, Sepsis, Urinary tract infection, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 335 | 26893982 |
CA |
67 | 2 |
Nephrolithiasis, Renal pain, Back pain, Urinary tract infection, |
||||
INFLIXIMAB, |
||||
| 336 | 26894324 |
CA |
59 | 1 |
Pyelonephritis acute, Febrile neutropenia, Nephrostomy, Urinary tract infection, |
||||
CARBOPLATIN, ETOPOSIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DENOSUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FENTANYL, LORAZEPAM, MELATONIN, MORPHINE, MIRABEGRON, OLANZAPINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RELUGOLIX, PEGFILGRASTIM, POLYETHYLENE GLYCOL, PREGABALIN, PROCHLORPERAZINE, |
||||
| 337 | 26894342 |
US |
2 | |
Food poisoning, Urinary tract infection, Abdominal pain upper, Diarrhoea, |
||||
TIRZEPATIDE, |
||||
| 338 | 26894515 |
US |
2 | |
Unresponsive to stimuli, Blood glucose decreased, Fall, Urinary tract infection, Contusion, Swelling face, |
||||
RAVULIZUMAB, |
||||
| 339 | 26894527 |
US |
73 | 2 |
Diarrhoea, Atrial fibrillation, Urinary tract infection, Joint stiffness, Dysstasia, Dehydration, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 340 | 26894701 |
US |
73 | 2 |
Urinary tract infection, Stress, Condition aggravated, Product prescribing issue, |
||||
| 341 | 26895327 |
CA |
1 | |
Breakthrough haemolysis, Viral infection, Urinary tract infection, Fatigue, |
||||
RAVULIZUMAB, |
||||
| 342 | 26895655 |
EU |
2 | |
Rheumatoid arthritis, Rheumatoid arthritis, Rheumatoid arthritis, Diverticulum intestinal, Psoriasis, Osteoarthritis, Oral herpes, Rheumatoid arthritis, Influenza like illness, Influenza like illness, Pancreatic steatosis, Upper respiratory tract infection, Bronchitis chronic, Dyspnoea exertional, Rheumatoid arthritis, Sleep disorder, Rheumatoid nodule, Urinary tract infection, Respiratory tract infection, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 343 | 26895743 |
US |
85 | |
Urinary tract infection, |
||||
SUZETRIGINE, |
||||
| 344 | 26895947 |
US |
37 | 2 |
Tuberculosis, Memory impairment, Scoliosis, Gastrointestinal infection, Fatigue, Urinary tract infection, Uveitis, Mood swings, |
||||
OMAVELOXOLONE, OMAVELOXOLONE, |
||||
| 345 | 26896127 |
IR |
57 | 2 |
Pneumonia, Urinary tract infection, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, CLOPIDOGREL, NATALIZUMAB, ROSUVASTATIN, |
||||
| 346 | 26896496 |
EU |
34 | 2 |
Arm amputation, Embolism arterial, Peripheral ischaemia, Soft tissue necrosis, Infarction, Paradoxical embolism, Arterial occlusive disease, Genital herpes, Cardiac ventricular thrombosis, Thrombocytosis, Microcytic anaemia, Urinary tract infection, Pulmonary embolism, Chest pain, Product use in unapproved indication, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE, SUMATRIPTAN SUCCINATE, OXAZEPAM, OXAZEPAM, OXAZEPAM, OXAZEPAM, INDOMETHACIN, INDOMETHACIN, INDOMETHACIN, INDOMETHACIN, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 347 | 26896810 |
US |
63 | 2 |
Urinary tract infection, |
||||
DIROXIMEL FUMARATE, GABAPENTIN, ERGOCALCIFEROL, EZETIMIBE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 348 | 26896968 |
72 | 2 | |
Urinary tract infection, Escherichia infection, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 349 | 26897025 |
64 | 2 | |
Oxygen saturation decreased, Urinary tract infection, Anxiety, |
||||
| 350 | 26897269 |
93 | 2 | |
Skin ulcer, Urinary tract infection, Intercepted product prescribing error, |
||||
INSULIN LISPRO, |
||||
| 351 | 26897386 |
US |
2 | |
Nephrolithiasis, Blindness, Psoriasis, Headache, Urinary tract infection, Condition aggravated, |
||||
ECULIZUMAB, |
||||
| 352 | 26886749 |
US |
74 | 2 |
Dehydration, Nausea, Retching, Urinary tract infection, Blood magnesium decreased, Blood potassium decreased, Feeding disorder, Fluid intake reduced, |
||||
| 353 | 26887109 |
GB |
2 | |
Dysuria, Urinary tract infection, Off label use, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, CLARITHROMYCIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 354 | 26887680 |
GB |
35 | 2 |
Malaise, Urinary tract infection, Multiple sclerosis relapse, |
||||
OCRELIZUMAB, |
||||
| 355 | 26887686 |
CA |
32 | 2 |
Abdominal pain, Anxiety, Asthma, Bacterial infection, Blood pressure increased, Cough, Decreased activity, Diarrhoea, Dizziness, Dyspnoea, Dyspnoea exertional, Ear infection, Eczema, Emphysema, Eosinophil count abnormal, Feeding disorder, Forced expiratory volume decreased, Full blood count abnormal, Fungal infection, Heart rate increased, Infection, Influenza, Loss of personal independence in daily activities, Malaise, Migraine, Middle insomnia, Musculoskeletal chest pain, Nasal congestion, Nasal discharge discolouration, Nasopharyngitis, Pneumonia, Obstructive airways disorder, Oropharyngeal pain, Pain, Productive cough, Psoriasis, Rales, Restrictive pulmonary disease, Rhinitis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Stress, Tachycardia, Terminal insomnia, Tooth abscess, Upper-airway cough syndrome, Urinary tract infection, Urticaria, Vertigo, Vomiting, Wheezing, Drug ineffective, Therapeutic product effect decreased, Therapeutic response decreased, Product administration error, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, OMALIZUMAB, |
||||
| 356 | 26887795 |
JP |
82 | 2 |
Pemphigoid, Muscular weakness, Gait disturbance, Urinary tract infection, |
||||
LENALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 357 | 26887827 |
US |
||
Herpes virus infection, Urinary tract infection, Herpes zoster, |
||||
RAVULIZUMAB, |
||||
| 358 | 26887842 |
US |
1 | |
Urinary tract infection, Asthenia, |
||||
TEPROTUMUMAB, |
||||
| 359 | 26888150 |
EU |
||
Pneumonia, Pneumonia fungal, Urinary tract infection, |
||||
RITUXIMAB, POLATUZUMAB VEDOTIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, |
||||
| 360 | 26888320 |
CA |
58 | |
Urinary tract infection, Sinusitis, Influenza like illness, |
||||
OMALIZUMAB, OMALIZUMAB, PREDNISONE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, APIXABAN, SOTALOL HYDROCHLORIDE, ROSUVASTATIN, HYDROCORTISONE, CALCIUM, ERGOCALCIFEROL, MOMETASONE FUROATE, ALBUTEROL SULFATE, |
||||
| 361 | 26888336 |
EU |
2 | |
Abdominal distension, Insomnia, Ageusia, Burning sensation, Headache, Urinary tract infection, Blood urine present, Varicose vein, |
||||
AMLODIPINE, EDOXABAN TOSYLATE, NEBIVOLOL HYDROCHLORIDE, FUROSEMIDE, |
||||
| 362 | 26888348 |
CA |
28 | |
Weight decreased, Oropharyngeal pain, Postpartum state, Urinary tract infection, Illness, Drug level below therapeutic, Exposure during pregnancy, Suspected off label use, Overdose, Product dose omission issue, Intentional dose omission, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, SERTRALINE, |
||||
| 363 | 26888369 |
US |
59 | |
Urinary tract infection, |
||||
INFLIXIMAB-DYYB, |
||||
| 364 | 26888382 |
US |
74 | 2 |
Urinary tract infection, |
||||
LENALIDOMIDE, |
||||
| 365 | 26888475 |
BR |
73 | 1 |
Urinary tract infection, Inappropriate schedule of product administration, |
||||
VEDOLIZUMAB, |
||||
| 366 | 26888693 |
CA |
54 | 2 |
Feeling cold, Immunotoxicity, Rash pruritic, Urinary tract infection, Weight fluctuation, Blister, Chills, Constipation, Diarrhoea, Dry eye, Fatigue, Hypoaesthesia, Nausea, Visual impairment, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, ACETAMINOPHEN, SENNOSIDES, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ONDANSETRON HYDROCHLORIDE, |
||||
| 367 | 26888901 |
US |
12 | 1 |
Pneumonia aspiration, Cardiac disorder, Hypotension, Respiratory distress, Urinary tract infection, Ventricular dysfunction, Drug ineffective, Blood electrolytes decreased, Pneumonia, Cough, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, ALBUTEROL SULFATE, AMOXICILLIN AND CLAVULANATE POTASSIUM, CANNABIDIOL, DIAZEPAM, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LEVALBUTEROL TARTRATE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, TOPIRAMATE, CLONAZEPAM, |
||||
| 368 | 26889462 |
EU |
2 | |
Pneumonia, Urinary tract infection, Dysphonia, |
||||
OFATUMUMAB, |
||||
| 369 | 26889520 |
CA |
51 | 1 |
Abdominal pain, Defaecation urgency, Diarrhoea, Frequent bowel movements, Gastrointestinal pain, Haematochezia, Inflammatory marker increased, Pain, Urinary tract infection, |
||||
| 370 | 26889934 |
CO |
6 | 2 |
Bronchiolitis, Urinary tract infection, Influenza, Cough, |
||||
PALIVIZUMAB, |
||||
| 371 | 26890138 |
US |
40 | 2 |
Sepsis, Colitis ulcerative, Therapeutic product effect incomplete, Hidradenitis, Skin infection, Urinary tract infection, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 372 | 26890185 |
US |
77 | 2 |
Urinary tract infection, |
||||
POMALIDOMIDE, |
||||
| 373 | 26890441 |
CA |
37 | 1 |
IgA nephropathy, Urinary tract infection, Weight decreased, |
||||
| 374 | 26890718 |
GB |
31 | 1 |
Illness, Lower respiratory tract infection, Myalgia, Cough, Urinary tract infection, Injection site extravasation, Nausea, Injection site hypoaesthesia, Asthenia, Dizziness, Laryngitis, |
||||
OFATUMUMAB, |
||||
| 375 | 26891420 |
US |
27 | 2 |
Discomfort, Mobility decreased, Fatigue, Urinary tract infection, Anxiety, |
||||
ZURANOLONE, |
||||
| 376 | 26891435 |
US |
2 | |
Urinary tract infection, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 377 | 26891538 |
US |
87 | 2 |
Device use error, Device difficult to use, Drug dose omission by device, Injection site pain, Urinary tract infection, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 378 | 26891615 |
MY |
69 | 1 |
Septic shock, Renal abscess, Urinary tract infection, |
||||
DAPAGLIFLOZIN, |
||||
| 379 | 26891746 |
US |
85 | 2 |
Bacterial infection, Musculoskeletal pain, Hypertension, Dizziness, Urinary tract infection, Neck pain, Arthritis, Arthralgia, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 380 | 26891822 |
US |
1 | |
Urinary tract infection, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, CARVEDILOL, FUROSEMIDE, ERGOCALCIFEROL, SILDENAFIL CITRATE, SILDENAFIL, INSULIN GLARGINE, GLIMEPIRIDE, OXYGEN, 0XYGEN, TIZANIDINE HYDROCHLORIDE, ROSUVASTATIN, LEVOTHYROXINE SODIUM, |
||||
| 381 | 26894051 |
|||
Urinary tract infection, Therapy interrupted, |
||||
BOSENTAN, |
||||
| 382 | 26895699 |
92 | 2 | |
Loss of consciousness, Urinary tract infection, Rash, |
||||
LENALIDOMIDE, |
||||
| 383 | 26881400 |
US |
80 | 2 |
Urinary tract infection, Back pain, Incontinence, |
||||
MAVACAMTEN, MAVACAMTEN, |
||||
| 384 | 26881464 |
60 | 2 | |
Anal fistula, Urinary incontinence, Urinary tract infection, Off label use, Malaise, Dysuria, Surgery, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREGABALIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, SULFASALAZINE, |
||||
| 385 | 26882148 |
JP |
||
Enterovesical fistula, Urinary tract infection, |
||||
CEMIPLIMAB-RWLC, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 386 | 26882200 |
IN |
39 | 1 |
Aplasia pure red cell, Bacterial pyelonephritis, Pseudomonas infection, Burkholderia cepacia complex infection, Urosepsis, Tuberculosis, Pyrexia, Parvovirus B19 infection, Urinary tract infection, Klebsiella infection, |
||||
ANTI-THYMOCYTE GLOBULIN (RABBIT), TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, SIROLIMUS, |
||||
| 387 | 26882411 |
EU |
27 | 2 |
Ovarian cyst ruptured, Urinary tract infection, Influenza like illness, Infectious mononucleosis, Dyspepsia, |
||||
ATOGEPANT, ERGOCALCIFEROL, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 388 | 26882608 |
US |
82 | 2 |
Urinary tract infection, Urethral haemorrhage, |
||||
| 389 | 26882642 |
EU |
46 | |
Polyneuropathy, Oropharyngeal pain, Hypoaesthesia, Pain in jaw, Vascular access site pain, Oral herpes, Headache, Dry skin, Acne, Asthenia, Urinary tract infection, Dysgeusia, Diarrhoea, Nausea, Bone pain, Mucosal inflammation, Urticaria, |
||||
TRASTUZUMAB, PERTUZUMAB, |
||||
| 390 | 26882730 |
US |
2 | |
Diabetes mellitus, Urinary tract infection, |
||||
CAPIVASERTIB, |
||||
| 391 | 26883285 |
CN |
54 | 2 |
Myelosuppression, Urinary tract infection, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 392 | 26883558 |
76 | 1 | |
Urinary tract infection, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 393 | 26883818 |
EU |
51 | 1 |
Urinary tract infection, Calculus bladder, Neoplasm, |
||||
OCRELIZUMAB, OCRELIZUMAB, ENOXAPARIN SODIUM, PANTOPRAZOLE, |
||||
| 394 | 26883892 |
EU |
57 | 1 |
Urinary tract infection, Stoma site infection, Pyrexia, Urinary incontinence, Stoma site discharge, Stoma site odour, |
||||
| 395 | 26884045 |
CA |
56 | 2 |
Urinary tract infection, Pneumonia, Mobility decreased, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
| 396 | 26884617 |
US |
1 | |
Urinary tract infection, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 397 | 26885006 |
2 | ||
Urinary tract infection, Dehydration, Renal impairment, |
||||
PALBOCICLIB, |
||||
| 398 | 26885259 |
|||
Urinary tract infection, Nausea, Hot flush, Hyperhidrosis, Anxiety, Depressed mood, |
||||
PALBOCICLIB, |
||||
| 399 | 26885297 |
EU |
75 | 2 |
Nephrolithiasis, Urinary tract infection, Malaise, Diarrhoea, Abdominal discomfort, Nausea, Constipation, |
||||
TERIPARATIDE, LOSARTAN, HYDROCHLOROTHIAZIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, SIMVASTATIN, |
||||
| 400 | 26885345 |
US |
57 | |
Urinary tract infection, Application site pruritus, |
||||
RUXOLITINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30